The Cancer Foundation for Personal Appearance celebrates its 2012 Tribute and Salute Dinner! Congratulations to Joseph Minniti, Founder and Director, and to everyone at the foundation who has…
NEW YORK (Reuters Health) – Men with isolated high-grade prostatic intraepithelial neoplasia (HGPIN) are at relatively high risk for developing prostate cancer, and treatment with toremifene does not…
NEW YORK (Reuters Health) – Among patients undergoing liver transplantation for hepatocellular carcinoma, the risk of recurrence is lower when immunosuppression is based on sirolimus rather than calcineurin…
NEW YORK (Reuters Health) – A French team reports some advantages with robot-assisted compared to conventional laparoscopic radical prostatectomy performed via an extraperitoneal approach. “This study did not…
Lee Krug, MD, discusses the current state of mesothelioma treatments as well as new therapies in development. He mentions the possibilities of clinical trials for angiogenesis inhibitors and anti-VEGF antibodies for mesothelioma…
More than 2700 people lost their lives during the terrorist attacks on the World Trade Center in New York City. The attack also exposed hundreds of thousands of…
NEW YORK (Reuters Health) – Adding the anti-VEGF monoclonal antibody bevacizumab to FOLFOX chemotherapy does not improve outcomes in patients with stage II-III colon cancer, according to a…
ZURICH (Reuters) – Swiss pharma group Roche’s drug Perjeta (pertuzumab) significantly extended the lives of women with HER2-positive breast cancer compared to a placebo, according to new data…
NEW YORK (Reuters Health) – Compared to conventional cytology, liquid-based cytology is more than twice as sensitive in detecting cervical intraepithelial neoplasia (CIN) grade 2 or higher, without…
NEW YORK (Reuters Health) – After focal treatment of a limited number of brain metastases, whole-brain radiotherapy (WBRT) appears to have a negative impact on health-related quality of…